- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06668818
Clinical Nursing Practice Supported by Results of Research: Mixed-method Study (PRACTICE)
November 29, 2024 updated by: Centro di Riferimento Oncologico - Aviano
The purpose of the study is to assess the attitudes and the use of research by nurses at the IRCCS-CRO Aviano.
Furthermore, it will make it possible to identify attitudes towards the use/non-use of research results, specific training needs and targeted interventions to ensure adequate care for cancer patients along the disease course, derived from a constant updating of nursing skills.
The study will involve nurses working in different care settings of the Institute and some patients who will be able to express their care needs and research priorities, making a direct contribution towards development of care centred on the health needs, preferences and values of the cancer patients.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
205
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lucia Cadorin, PhD
- Phone Number: 0434 659508
- Email: lcadorin@cro.it
Study Locations
-
-
Pordenone
-
Aviano, Pordenone, Italy, 33081
- Recruiting
- Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
-
Contact:
- Lucia Cadorin, PhD
- Phone Number: 0434 659508
- Email: lcadorin@cro.it
-
Principal Investigator:
- Lucia Cadorin, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Nurses employed at IRCCS-CRO Aviano and patients admitted to the institution as in-patients
Description
Inclusion criteria for nurses:
- All nurses employed at IRCCS-CRO Aviano under fixed-term and permanent contract on 15 September 2023;
- Nursing activities in the departments of medical and surgical oncology and high technologies;
- Full-time and part-time employment contract;
- Signature of consent for participation in the study and processing of personal data (Privacy).
Patient inclusion criteria:
- Patients admitted to the institution as in-patients;
- Age ≥ 18 years;
- Signature of consent for participation in the study and processing of personal data (Privacy);
- Good understanding of the Italian language.
Exclusion criteria for nurses:
- Lack of willingness/interest in participating in the study and signing the consent.
Patient exclusion criteria:
- Day-Hospital patients;
- Age < 18 years;
- Diagnosis of cognitive dysfunction or psychiatric disorders;
- Difficulties in understanding the Italian language.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Nurses employed at IRCCS-CRO Aviano
|
|
Patients admitted to the IRCCS-CRO Aviano as in-patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To assess the attitudes and use of research by nurses IRCCS of Aviano
Time Frame: 1 year
|
The Modified Research Utilization Questionnaire (M-RUQ), consisting of 22 items across three subscales assessed on a 5-point Likert scale (range: 22-110), will be used for data collection.
Total scores are computed by summing and averaging domain scores, with reverse-scoring for negative items.
Missing data will be imputed with item means, and results presented as mean ± standard deviation.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To identify nursing issues, research priorities, and educational needs of nurses at IRCCS Aviano.
Time Frame: 1 year
|
he qualitative data obtained from the research (using interview and focus group method) will be evaluated with inductive content analysis, following Colaizzi's framework (1978).
In order to enhance the validity of the data, two researchers will independently examine the transcripts, and comprehensive readings will be conducted.
Codes will be generated and compared by interpreting differences and similarities, from which themes and sub-themes will be obtained
|
1 year
|
|
To explore care needs and research priorities of patients at IRCCS Aviano
Time Frame: 1 year
|
he qualitative data obtained from the research (using interview and focus group method) will be evaluated with inductive content analysis, following Colaizzi's framework (1978).
In order to enhance the validity of the data, two researchers will independently examine the transcripts, and comprehensive readings will be conducted.
Codes will be generated and compared by interpreting differences and similarities, from which themes and sub-themes will be obtained
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lucia Cadorin, PhD, Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 7, 2024
Primary Completion (Estimated)
March 7, 2025
Study Completion (Estimated)
March 7, 2025
Study Registration Dates
First Submitted
October 30, 2024
First Submitted That Met QC Criteria
October 30, 2024
First Posted (Actual)
October 31, 2024
Study Record Updates
Last Update Posted (Actual)
December 3, 2024
Last Update Submitted That Met QC Criteria
November 29, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRO-2023-83
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oncology
-
Çanakkale Onsekiz Mart UniversityActive, not recruitingOncology | Physiology | Geriatric OncologyTurkey (Türkiye)
-
Blokhin's Russian Cancer Research CenterRecruitingOncology | Oncology Patients Receiving Chemotherapy | Cachexia-Anorexia SyndromeRussia
-
State University of New York at BuffaloRecruitingMedical Oncology | Integrative Oncology | Medical Nutrition TherapyUnited States
-
State University of New York at BuffaloRecruitingMedical Oncology | Integrative Oncology | Medical Nutrition TherapyUnited States
-
MaineHealthTufts Medical CenterRecruitingOncology | Prehabilitation | Surgical OncologyUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
University of Wisconsin, MadisonRecruiting